Facilitated by ROKIT’s U.S. partner, Tides Medical, the agreement enables Alliant’s member hospitals and clinics to access ROKIT’s advanced regenerative medicine products. Alliant collaborates with healthcare systems to secure bulk purchasing contracts, balancing cost efficiency with high-quality care standards.
The deal marks a strategic move by ROKIT to deepen its presence in the U.S. healthcare market, where GPOs like Alliant play a pivotal role in shaping hospital procurement and driving the adoption of innovative medical technologies.
“This partnership not only opens doors to healthcare providers but also creates opportunities across diverse industries,” a ROKIT Healthcare spokesperson said. “It’s a vital step toward expanding our global supply chain and strengthening our market position.”
Kim Kuk Ju, HEALTH IN NEWS TEAM
press@hinews.co.kr
